Objective: To determine the independent and synergistic effects of amyloid and small vessel
disease (SVD) burden on longitudinal cognitive decline in patients with subcortical vascular …

Objective To evaluate the association between brain amyloid β (Aβ) and cerebral small
vessel disease (CSVD) markers, as well as their joint effect on cognition, in a memory clinic …

Background and purpose Biomarker changes in cognitively impaired patients with small
vessel disease are largely unknown. The rate of amyloid/lacune progression, cortical …

Objectives: Despite many neuropsychological studies to differentiate subcortical vascular
dementia (SVaD) from Alzheimer disease (AD), previous studies did not eliminate …

Objective: To evaluate the differences between early-onset subcortical vascular cognitive
impairment (EO-SVCI) and late-onset subcortical vascular cognitive impairment (LO-SVCI) …

Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in
subjects with cognitive impairment. However, the relationship between CVD, amyloid …

Objective To determine whether demographic data, dementia severity, functional status,
whole brain volume (WBV), or subcortical hyperintensity volume (SH) predict subsequent …

Background Vascular cognitive impairment (VCI) is a heterogeneous entity with multiple
aetiologies, all linked to underlying vascular disease. Among these, VCI related to …

Background: As Alzheimer's disease (AD) and cerebral small vessel disease (CSVD)
commonly coexist, the interaction between two has been of the considerable interest …

Neuropsychiatric symptoms (NPS) affect the quality of life of patients with dementia and
increase the burden on caregivers. We aimed to evaluate how small vessel disease (SVD) …